Weekly Investment Analysts’ Ratings Changes for Veracyte (VCYT)

Chronological Source Flow
Back

AI Fusion Summary

Veracyte’s analyst sentiment stays mixed. Needham keeps a buy with a $48 target, while Guggenheim cut its target to $45. Morgan Stanley lowered its target to $37 and shifted to underweight. Zacks downgraded to hold, and Weiss held a hold.
#Veracyte #analyst ratings #buy #hold #price target #Morgan Stanley #Needham
02/04 09:16 defenseworld.net
3 Πηγές

Weekly Investment Analysts’ Ratings Changes for Veracyte (VCYT)

Veracyteanalyst ratingsbuyholdprice targetMorgan Stanley
02/04 11:10 defenseworld.net

Analysts’ Weekly Ratings Changes for Honeywell International (HON)

ANALYST ARTICLES - COMPANY SUMCOMPANIESPOLITICS
02/04 11:10 defenseworld.net

Analysts’ Weekly Ratings Changes for Altius Minerals (ALS)

ANALYST ARTICLES - COMPANY SUMCOMPANIESPOLITICSECONOMY
Comments
Loading...
0